Extended interval dosing of natalizumab: a two-center, 7-year experience. Bomprezzi R, Pawate S Ther Adv Neurol Disord. 2014 Sep; 7(5):227-31. PMID: 25342976. Abstract CommentRecommendBookmarkWatch